Zonghan Dai

2.1k total citations · 1 hit paper
29 papers, 1.8k citations indexed

About

Zonghan Dai is a scholar working on Molecular Biology, Hematology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Zonghan Dai has authored 29 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Hematology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Zonghan Dai's work include Chronic Myeloid Leukemia Treatments (10 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Zonghan Dai is often cited by papers focused on Chronic Myeloid Leukemia Treatments (10 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Zonghan Dai collaborates with scholars based in United States, China and Canada. Zonghan Dai's co-authors include Ann Marie Pendergast, Channing J. Der, Larry D. Cripe, Joseph Schlessinger, Mikhail L. Gishizky, Craig H. Bassing, Lawrence A. Quilliam, Andreas Batzer, Ping Ye and Yuzhe Xing and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Zonghan Dai

28 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein

1993 549 citations Ann Marie Pendergast, Lawrence A. Quilliam et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zonghan Dai United States	20	1.0k	650	405	261	242	29	1.8k
Marc Valentine United States	19	932 0.9×	67 0.1×	321 0.8×	188 0.7×	76 0.3×	31	1.7k
Franck Gesbert France	20	1.1k 1.1×	585 0.9×	374 0.9×	19 0.1×	270 1.1×	35	2.0k
Mary Shago Canada	21	1.4k 1.4×	112 0.2×	224 0.6×	67 0.3×	233 1.0×	57	2.3k
Daniel Sherman United States	10	1.1k 1.1×	163 0.3×	125 0.3×	83 0.3×	201 0.8×	13	1.6k
Michelina Iacovino United States	28	2.4k 2.4×	213 0.3×	144 0.4×	174 0.7×	413 1.7×	57	3.1k
Melih Acar United States	17	1.2k 1.2×	623 1.0×	358 0.9×	17 0.1×	529 2.2×	26	2.3k
Geraldine Mbamalu Canada	17	2.9k 2.9×	411 0.6×	300 0.7×	41 0.2×	1.1k 4.6×	20	4.0k
Sachiko I. Blaber United States	31	826 0.8×	862 1.3×	1.2k 2.9×	20 0.1×	153 0.6×	45	2.1k
M Moos Germany	18	742 0.7×	467 0.7×	190 0.5×	24 0.1×	107 0.4×	32	1.5k
C. Crawford United States	3	727 0.7×	258 0.4×	127 0.3×	22 0.1×	124 0.5×	6	1.2k

Countries citing papers authored by Zonghan Dai

Since Specialization

Citations

This map shows the geographic impact of Zonghan Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zonghan Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zonghan Dai more than expected).

Fields of papers citing papers by Zonghan Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zonghan Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zonghan Dai. The network helps show where Zonghan Dai may publish in the future.

Co-authorship network of co-authors of Zonghan Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Zonghan Dai. A scholar is included among the top collaborators of Zonghan Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zonghan Dai. Zonghan Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Peixin, et al.. (2022). The Abl/Abi signaling links WAVE regulatory complex to Cbl E3 ubiquitin ligase and is essential for breast cancer cell metastasis. Neoplasia. 32. 100819–100819. 1 indexed citations

Faulkner, James, et al.. (2020). CRISPR/CAS9-mediated knockout of Abi1 inhibits p185Bcr-Abl-induced leukemogenesis and signal transduction to ERK and PI3K/Akt pathways. Journal of Hematology & Oncology. 13(1). 34–34. 9 indexed citations

Li, Mei, Yulan Liu, Kun Li, et al.. (2014). G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr–Abl-induced transformation and leukemogenesis. Leukemia & lymphoma. 56(7). 2170–2181. 13 indexed citations

Liu, Bin, et al.. (2012). Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease. BMC Nephrology. 13(1). 109–109. 29 indexed citations

Tang, Hongxing, et al.. (2011). CDK1-mediated Phosphorylation of Abi1 Attenuates Bcr-Abl-induced F-actin Assembly and Tyrosine Phosphorylation of WAVE Complex during Mitosis. Journal of Biological Chemistry. 286(44). 38614–38626. 13 indexed citations

Li, Chenghai, Bin Liu, Zonghan Dai, & Yunxia Tao. (2011). Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC). Cancer Biology & Therapy. 12(10). 872–880. 51 indexed citations

Yu, Weidong, Xiaolin Sun, Hongxing Tang, Yunxia Tao, & Zonghan Dai. (2010). Inhibition of class II phosphoinositide 3-kinase γ expression by p185^Bcr–Ablcontributes to impaired chemotaxis and aberrant homing of leukemic cells. Leukemia & lymphoma. 51(6). 1098–1107. 5 indexed citations

Sun, Xiaolin, Chunying Li, William Gilmore, et al.. (2009). Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells. Carcinogenesis. 30(12). 2109–2116. 37 indexed citations

Yu, Wenhua, et al.. (2008). Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo. Carcinogenesis. 29(9). 1717–1724. 32 indexed citations

10.

Sun, Xiaolin, et al.. (2007). Bcr-Abl induces abnormal cytoskeleton remodeling, β1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway. Journal of Cell Science. 120(8). 1436–1446. 38 indexed citations

11.

Dai, Zonghan, et al.. (2001). Deletion of the Src Homology 3 Domain and C-terminal Proline-rich Sequences in Bcr-Abl Prevents Abl Interactor 2 Degradation and Spontaneous Cell Migration and Impairs Leukemogenesis. Journal of Biological Chemistry. 276(31). 28954–28960. 32 indexed citations

12.

Dai, Zonghan, Robert C. Quackenbush, Kevin D. Courtney, et al.. (1998). Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes & Development. 12(10). 1415–1424. 98 indexed citations

13.

Ye, Ping, et al.. (1996). In vivo actions of insulin-like growth factor-I (IGF-I) on cerebellum development in transgenic mice: evidence that IGF-I increases proliferation of granule cell progenitors. Developmental Brain Research. 95(1). 44–54. 136 indexed citations

14.

D’Ercole, A. Joseph, P. Ye, & Zonghan Dai. (1995). Human insulin-like growth factor binding protein-1 (hiGFBP-1) transgenic mice: Insights into hIGFBP-1 regulation and actions. PubMed. 6(2-4). 417–423. 6 indexed citations

15.

Dai, Zonghan & Ann Marie Pendergast. (1995). Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity.. Genes & Development. 9(21). 2569–2582. 235 indexed citations

16.

Dai, Zonghan, Yixiao Xing, Charlotte M. Boney, David R. Clemmons, & A. Joseph D’Ercole. (1994). Human insulin-like growth factor-binding protein-1 (hIGFBP-1) in transgenic mice: characterization and insights into the regulation of IGFBP-1 expression.. Endocrinology. 135(4). 1316–1327. 62 indexed citations

17.

Dai, Zonghan, et al.. (1994). Brain growth retardation due to the expression of human insulin like growth factor binding protein-1 in transgenic mice: an in vivo model for the analysis of igf function in the brain. Developmental Brain Research. 82(1-2). 213–222. 69 indexed citations

18.

Backeljauw, Philippe, Zonghan Dai, David R. Clemmons, & A. Joseph D’Ercole. (1993). Synthesis and regulation of insulin-like growth factor binding protein-5 in FRTL-5 cells.. Endocrinology. 132(4). 1677–1681. 29 indexed citations

19.

Pendergast, Ann Marie, Lawrence A. Quilliam, Larry D. Cripe, et al.. (1993). BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell. 75(1). 175–185. 549 indexed citations breakdown →

20.

Dai, Zonghan. (1992). Creation of an autocrine model of insulin-like growth factor-I action in transfected FRTL-5 cells. Endocrinology. 130(6). 3175–3183. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact